124 related articles for article (PubMed ID: 16078846)
21. Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology.
Nakahata N
Pharmacol Ther; 2008 Apr; 118(1):18-35. PubMed ID: 18374420
[TBL] [Abstract][Full Text] [Related]
22. P2Y1 receptor antagonists as novel antithrombotic agents.
Pfefferkorn JA; Choi C; Winters T; Kennedy R; Chi L; Perrin LA; Lu G; Ping YW; McClanahan T; Schroeder R; Leininger MT; Geyer A; Schefzick S; Atherton J
Bioorg Med Chem Lett; 2008 Jun; 18(11):3338-43. PubMed ID: 18445527
[TBL] [Abstract][Full Text] [Related]
23. New developments on thromboxane and prostacyclin modulators part I: thromboxane modulators.
Dogné JM; de Leval X; Hanson J; Frederich M; Lambermont B; Ghuysen A; Casini A; Masereel B; Ruan KH; Pirotte B; Kolh P
Curr Med Chem; 2004 May; 11(10):1223-41. PubMed ID: 15134516
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and biological evaluation of hydrogen sulfide releasing derivatives of 3-n-butylphthalide as potential antiplatelet and antithrombotic agents.
Wang X; Wang L; Sheng X; Huang Z; Li T; Zhang M; Xu J; Ji H; Yin J; Zhang Y
Org Biomol Chem; 2014 Aug; 12(31):5995-6004. PubMed ID: 24988475
[TBL] [Abstract][Full Text] [Related]
25. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
Vilahur G; Casaní L; Badimon L
Thromb Haemost; 2007 Sep; 98(3):662-9. PubMed ID: 17849057
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparations.
Buccellati C; Sala A; Rossoni G; Capra V; Rovati GE; Di Gennaro A; Folco G; Colli S; Casagrande C
J Pharmacol Exp Ther; 2006 May; 317(2):830-7. PubMed ID: 16399881
[TBL] [Abstract][Full Text] [Related]
27. Effects of higenamine and its 1-naphthyl analogs, YS-49 and YS-51, on platelet TXA2 synthesis and aggregation.
Pyo MK; Kim JM; Jin JL; Chang KC; Lee DH; Yun-Choi HS
Thromb Res; 2007; 120(1):81-6. PubMed ID: 17020781
[TBL] [Abstract][Full Text] [Related]
28. Metabolism-based identification of a potent thrombin receptor antagonist.
Clasby MC; Chackalamannil S; Czarniecki M; Doller D; Eagen K; Greenlee W; Kao G; Lin Y; Tsai H; Xia Y; Ahn HS; Agans-Fantuzzi J; Boykow G; Chintala M; Foster C; Smith-Torhan A; Alton K; Bryant M; Hsieh Y; Lau J; Palamanda J
J Med Chem; 2007 Jan; 50(1):129-38. PubMed ID: 17201416
[TBL] [Abstract][Full Text] [Related]
29. A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient mice.
Cyrus T; Yao Y; Ding T; Dogné JM; Praticò D
Eur J Pharmacol; 2007 Apr; 561(1-3):105-11. PubMed ID: 17306791
[TBL] [Abstract][Full Text] [Related]
30. Novel benzodifuran analogs as potent 5-HT2A receptor agonists with ocular hypotensive activity.
Feng Z; Mohapatra S; Klimko PG; Hellberg MR; May JA; Kelly C; Williams G; McLaughlin MA; Sharif NA
Bioorg Med Chem Lett; 2007 Jun; 17(11):2998-3002. PubMed ID: 17419053
[TBL] [Abstract][Full Text] [Related]
31. 2-[4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide (NS-304), an orally available and long-acting prostacyclin receptor agonist prodrug.
Kuwano K; Hashino A; Asaki T; Hamamoto T; Yamada T; Okubo K; Kuwabara K
J Pharmacol Exp Ther; 2007 Sep; 322(3):1181-8. PubMed ID: 17545310
[TBL] [Abstract][Full Text] [Related]
32. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor.
Guerrero JA; Lozano ML; Castillo J; Benavente-García O; Vicente V; Rivera J
J Thromb Haemost; 2005 Feb; 3(2):369-76. PubMed ID: 15670046
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo effects of new powerful thromboxane antagonists (3-alkylamino pinane derivatives).
Katsura M; Miyamoto T; Hamanaka N; Kondo K; Terada T; Ohgaki Y; Kawasaki A; Tsuboshima M
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():351-7. PubMed ID: 6221545
[No Abstract] [Full Text] [Related]
34. Synthesis and evaluation of N-acylsulfonamide and N-acylsulfonylurea prodrugs of a prostacyclin receptor agonist.
Nakamura A; Yamada T; Asaki T
Bioorg Med Chem; 2007 Dec; 15(24):7720-5. PubMed ID: 17881233
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and SAR study of a series of N-alkyl-N'-[2-(aryloxy)-5-nitrobenzenesulfonyl]ureas and -cyanoguanidine as selective antagonists of the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor.
Hanson J; Dogné JM; Ghiotto J; Moray AL; Kinsella BT; Pirotte B
J Med Chem; 2007 Aug; 50(16):3928-36. PubMed ID: 17630727
[TBL] [Abstract][Full Text] [Related]
36. Antiplatelet and antithrombotic activity of indole-3-carbinol in vitro and in vivo.
Park MK; Rhee YH; Lee HJ; Lee EO; Kim KH; Park MJ; Jeon BH; Shim BS; Jung CH; Choi SH; Ahn KS; Kim SH
Phytother Res; 2008 Jan; 22(1):58-64. PubMed ID: 17724769
[TBL] [Abstract][Full Text] [Related]
37. Discovery of Potent Protease-Activated Receptor 4 Antagonists with in Vivo Antithrombotic Efficacy.
Miller MM; Banville J; Friends TJ; Gagnon M; Hangeland JJ; Lavallée JF; Martel A; O'Grady H; Rémillard R; Ruediger E; Tremblay F; Posy SL; Allegretto NJ; Guarino VR; Harden DG; Harper TW; Hartl K; Josephs J; Malmstrom S; Watson C; Yang Y; Zhang G; Wong P; Yang J; Bouvier M; Seiffert DA; Wexler RR; Lawrence RM; Priestley ES; Marinier A
J Med Chem; 2019 Aug; 62(16):7400-7416. PubMed ID: 31246024
[TBL] [Abstract][Full Text] [Related]
38. Cardioprotective prostacyclin signaling in vascular smooth muscle.
Fetalvero KM; Martin KA; Hwa J
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):109-18. PubMed ID: 17164138
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives.
Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN
Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386
[TBL] [Abstract][Full Text] [Related]
40. Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.
Saberi MR; Vinh TK; Yee SW; Griffiths BJ; Evans PJ; Simons C
J Med Chem; 2006 Feb; 49(3):1016-22. PubMed ID: 16451067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
